Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: betty moyers who wrote (18047)	1/22/1999 2:53:00 PM
From: VLAD	Respond to of 23519

betty, There isn't a person out there that hasn't been dumbfounded with the way this stock has been traded. The universal conclusion is that Vivus is a highly manipulated stock. If we compare Vivus to any other similar small cap biotech stocks (I have always found that the best similar comparisons include LIPO, CEPH, and ZONA) there is no reason (except for manipulation) for this stock not to be currently trading at least in the $8 to $10 range. Since I am so heavily invested in Vivus, I have no choice except to wait for the stock price to be manipulated back to what I consider to be fair market value. You just can't justify $3.00 for a biotech company that now is again profitable with a lot of promising future prospects. I guess we will just have to wait for the value investors to slowly accumulate. It already appears to me that the mms are having a difficult time churning the stock much to the direction of their desire (in todays case down again but only on 1/3 of average volume). Nothing has changed over the past 3 or 4 months. The Viagra disaster is now behind us. Leland IMO made more mistakes that I feel are considered unacceptable for a competent CEO. His complete lack of foresight regarding the impact of Viagra on MUSE sales along with allowing an incompetent (and I would add unethical) CFO to be allowed in charge of the company's cash was a receipe for disaster. I do have a lot of faith in the new CFO. He has done a wonderful job at cleaning up the mess he inherited. I think that most here are simply tired of waiting to see their investment remain under water while other stocks which we consider to be complete junk trade at obscene levels. This frustration is exactly what the manipulators wish to accomplish. They want us to give up and sell our stock into their cover below $3.00/share. So far they have had much success as they have been able to cover over 4.5M shares over the past 5 months with no increase in stock price. It's too bad that today's investors have little if any patience. With Leland Wilson at the helm patience is a virtue. His eyes have always been bigger than Vivus' resources which has resulted in these one step forward/two steps backwards results. At least he finally accepted (although being financially forced to do so) Vivus' limitations as a small biotech company accepting the fact that Vivus doesn't have the ability/resources to market its product. Although I still cringe when I look at the stock's price, I do see a bright future ahead for Vivus. Time will tell.